Özet:

Aim Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard treatment for pancreaticobiliary diseases. The aim of this study was to evaluate the safety and review the outcomes of ERCP over the past 4 years. Materials and Methods The clinical records of patients aged 18–104 years who underwent ERCP at our gastroenterology clinic between 2014 and 2018 were included in the study. Data were acquired from the hospital archive system. Results A total of 1337 patients underwent ERCP, of which 775 were female and 562 were male, and their mean age was 60.58 ± 17.96 years. Thirty-nine patients were aged 18–30 years, 694 were aged 30–65 years, 274 were aged 65–75 years, 258 were aged 75–85 years, and 72 were aged >85 years. Among them, 28.27% were rated III–IV on the American Society of Anesthesiologists scale. Although biliary cannulation with standard sphincterotomy was successful in 1303 patients (97.45%), it could not be performed in 34 patients (2.55%). Precut papillotomy was performed in 27 (79.41%) of 34 patients. Furthermore, no complication was observed in 1207 patients (90.27%), whereas 96 patients (7.18%) had minor and major procedure-related and anesthesia-related complications. The 30-day mortality rate was 1.64% (n=22). Conclusion We concluded that ERCP, which is currently performed entirely for therapeutic purposes, is safe and lifesaving, with high clinical success rates.

Anahtar Kelimeler: